Figure 1 (4ffc6b8e Figure 01)
Acebutolol Hydrochloride Capsule
Product Images NDC 50268-050
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 50268-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (4ffc6b8e Figure 02)
This is a chart showing adverse reactions to Acebutolol, Propranolol, Hydrochlorothiazide, and Placebo in a study conducted in the United States. The chart lists various body systems and the percentage of participants who experienced specific adverse reactions in each group. Some of the adverse reactions listed include chest pain, edema, depression, dizziness, fatigue, headache, rash, constipation, diarrhea, dyspepsia, flatulence, cough, and abnormal vision.*
Figure 3 (4ffc6b8e Figure 03)
Label 5026805015 Acebutolol Hci 2019 200mg
The text is a product label for Acebutolol Hydrochloride Capsules, which contain 200mg of acebutolol per capsule. It is a prescription drug and comes in a pack of 50 capsules. The label includes directions for use, drug information, and storage instructions. The drug is manufactured by AAKVARE, Inc, and the label has a barcode with the identifying number 50268-050-15.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
